Product Information
OFLOXACIN 0.3% EYE DROPS is a generic product labeled by Rising Pharma Holdings Inc., priced at $1.1136 per ML under NDC 64980051501. Its NADAC has been published 586 times since Jul 15, 2015.
FDA first approved this application on Feb 25, 2009. Its Orange Book therapeutic-equivalence code is AT.
Strength
3 mg/mL
Manufacturer
Rising Pharma Holdings Inc.NDC
64980051501
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
OFLOXACINApproval Type
Generic (ANDA)
FDA Application
ANDA078559FDA Approved
2/25/2009
TE Code
AT
On Market Since
12/15/2014
Pharmacological Classes
Price Statistics
The NADAC for OFLOXACIN 0.3% EYE DROPS has been published 586 times since Jul 15, 2015, and over the history we have for it it has declined 59.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1136 per ML |
|---|---|
| All-time high | $5.2277 (Mar 15, 2017) |
| All-time low | $0.8360 (Nov 20, 2024) |
| 52-week high | $1.1995 |
| 52-week low | $1.1022 |
| Median price | $1.9232 |
| Average price | $1.9616 |
| Largest weekly change | -50.8% (Apr 19, 2017) |
| Weeks tracked | 586 |
| Tracking since | Jul 15, 2015 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rising Pharma Holdings Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ofloxacin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Quinolone Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OFLOXACIN 0.3% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for OFLOXACIN 0.3% EYE DROPS, manufactured by Rising Pharma Holdings Inc., is $1.1136 per ML (NDC 64980051501), effective Sep 30, 2026.
How has the price of OFLOXACIN 0.3% EYE DROPS changed over time?
Over the history we have for it, the NADAC for OFLOXACIN 0.3% EYE DROPS has declined 59.7%. It has been tracked across 586 weekly CMS publications since Jul 15, 2015.
What are the highest and lowest recorded NADAC prices for OFLOXACIN 0.3% EYE DROPS?
Since Jul 15, 2015, the NADAC for OFLOXACIN 0.3% EYE DROPS has ranged from a low of $0.8360 (Nov 20, 2024) to a high of $5.2277 (Mar 15, 2017), with a median of $1.9232 per ML.
Are there cheaper alternatives to OFLOXACIN 0.3% EYE DROPS?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OFLOXACIN 0.3% EAR DROPS, is $0.9789 per ML — about 12% below OFLOXACIN 0.3% EYE DROPS.
Who manufactures OFLOXACIN 0.3% EYE DROPS?
OFLOXACIN 0.3% EYE DROPS (NDC 64980051501) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.